PLUS1
3.63
-0.05 (-1.36%)
-0.05 (-1.36%)
Upgrade to Real-Time
Premarket
Low
2.40
High
19.30
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Onconova Therapeutics Inc | ONTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.05 | -1.36% | 3.63 | 06:08:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.68 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.64 | 3.80 | 0.16 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 8 | 310 | - | 2.40 - 19.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 05:11:43 | formt | 207 | $ 3.63 | USD |
Period:
Draw Mode:
Onconova Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 57.28M | 15.78M | 15.71M | $ 231.00k | $ - | -1.95 | -3.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 8.40% |
Onconova Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.58 | 3.91 | 3.5298 | 3.70 | 482,052 | 0.05 | 1.4% |
| 1 Month | 4.90 | 6.7699 | 3.47 | 5.69 | 5,536,619 | -1.27 | -25.92% |
| 3 Months | 5.132 | 6.7699 | 3.47 | 5.64 | 2,034,419 | -1.50 | -29.27% |
| 6 Months | 6.00 | 11.00 | 3.47 | 8.24 | 6,016,851 | -2.37 | -39.5% |
| 1 Year | 2.898 | 19.30 | 2.40 | 9.52 | 19,726,201 | 0.732 | 25.26% |
| 3 Years | 61.00 | 62.50 | 1.027 | 7.50 | 11,867,660 | -57.37 | -94.05% |
| 5 Years | 384.00 | 582.00 | 1.027 | 11.12 | 7,373,523 | -380.37 | -99.05% |
Onconova Therapeutics Description
| Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. |
